Gale, A. J., Elias, D. J., Averell, P. M., Teirstein, P. S., Buck, M., Brown, S. D., . . . Finn, M. (2011). Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients.

Gale, Andrew J., Darlene J. Elias, Patricia M. Averell, Paul S. Teirstein, Mitchell Buck, Steven D. Brown, Zinaida Polonskaya, Andrew K. Udit, ja M.G Finn. Engineered Virus-like Nanoparticles Reverse Heparin Anticoagulation More Consistently Than Protamine in Plasma From Heparin-treated Patients. 2011.

Gale, Andrew J., et al. Engineered Virus-like Nanoparticles Reverse Heparin Anticoagulation More Consistently Than Protamine in Plasma From Heparin-treated Patients. 2011.